Drug Dose Delivery

Less than 1 min 06/05/21
Author name: John Ross

Drug dose delivery development, manufacturing and commercialisation trends: part I

Drug developers are increasingly turning to CDMOs to overcome delivery challenges as patient centricity has become of paramount importance in drug manufacturing. In this two-part series with Manufacturing Chemist, John Ross, President of Metrics Contract Services and Mayne Pharma US, explores the developments, processing trends and manufacturing techniques relative to current development pathways and traditional forms which are proving capable of delivering better therapeutics to patients. “In the OSD formulation space, drug developers still require help with classic challenges such as food effects on the absorption of certain drugs; the presence of food in the digestive tract can reduce the absorption of a drug and, therefore, its efficacy.” Read the full article here.


Related Content